Home/Filings/4/0000904454-25-000560
4//SEC Filing

Kaye Jack 4

Accession 0000904454-25-000560

CIK 0001590560other

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 5:01 PM ET

Size

20.9 KB

Accession

0000904454-25-000560

Insider Transaction Report

Form 4
Period: 2025-11-04
Kaye Jack
Director
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2025-11-04$7.37/sh+10,000$73,70030,439 total
  • Exercise/Conversion

    Ordinary Shares

    2025-11-04$5.37/sh+11,000$59,07031,439 total
  • Exercise/Conversion

    Ordinary Shares

    2025-11-04$14.08/sh+17,810$250,76538,249 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-11-0410,0000 total
    Exercise: $7.37Exp: 2027-06-29Ordinary Shares (10,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-11-0411,0000 total
    Exercise: $5.37Exp: 2027-01-27Ordinary Shares (11,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-11-0417,8100 total
    Exercise: $14.08Exp: 2032-06-15Ordinary Shares (17,810 underlying)
  • Sale

    Ordinary Shares

    2025-11-04$30.36/sh10,000$303,60020,439 total
  • Sale

    Ordinary Shares

    2025-11-04$30.34/sh11,000$333,74020,439 total
  • Sale

    Ordinary Shares

    2025-11-04$30.33/sh17,810$540,17720,439 total
Footnotes (7)
  • [F1]The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.20 to $30.79. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.16 to $30.75. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.90. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]The Stock Option vested 25% on June 30, 2018 and 6.25% quarterly thereafter.
  • [F6]The Stock Option vested in full on January 27, 2018.
  • [F7]The Stock Option vested in full on June 15, 2023.

Issuer

uniQure N.V.

CIK 0001590560

Entity typeother

Related Parties

1
  • filerCIK 0001376099

Filing Metadata

Form type
4
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 5:01 PM ET
Size
20.9 KB